A detailed history of Creative Planning transactions in Haemonetics Corp stock. As of the latest transaction made, Creative Planning holds 6,115 shares of HAE stock, worth $449,391. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,115
Previous 10,534 41.95%
Holding current value
$449,391
Previous $785,000 62.04%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$47.67 - $78.17 $210,653 - $345,433
-4,419 Reduced 41.95%
6,115 $298,000
Q2 2025

Aug 08, 2025

BUY
$56.04 - $74.77 $18,773 - $25,047
335 Added 3.28%
10,534 $785,000
Q1 2025

May 15, 2025

BUY
$59.34 - $80.05 $110,787 - $149,453
1,867 Added 22.41%
10,199 $648,000
Q4 2024

Feb 14, 2025

BUY
$71.16 - $93.38 $294,175 - $386,032
4,134 Added 98.48%
8,332 $650,000
Q3 2024

Oct 11, 2024

SELL
$72.45 - $91.58 $17,895 - $22,620
-247 Reduced 5.56%
4,198 $337,000
Q2 2024

Aug 15, 2024

BUY
$81.24 - $97.37 $361,111 - $432,809
4,445 New
4,445 $367,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.